Leadoptik develops microstructure imaging technology for interventional pulmonology procedures. Their LIA system provides real-time nodule assessment to enhance the precision of biopsy needle placement during minimally invasive procedures. This technology aims to narrow the knowledge gap and improve diagnostic accuracy in interventional pulmonology.
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AVFounders
Product
Problem
Confirming biopsy needle placement in small lung lesions during pulmonary procedures remains a significant challenge, hindering accurate diagnosis and treatment of early-stage lung cancer. Current methods often lack the precision needed to visualize the microstructure at the biopsy site in real-time. This can lead to sampling errors and delayed diagnoses.
Solution
Leadoptik's Last Inch Assessment™ (LIA™) technology provides real-time, high-resolution microstructure visualization during pulmonary biopsies, enhancing the accuracy of small lung lesion detection. The miniature imaging system integrates with standard biopsy tools, allowing clinicians to see the tissue microstructure at the "last inch" of the needle's reach. This enables immediate confirmation of needle placement within the targeted lesion, improving sampling accuracy and diagnostic confidence. The technology aims to narrow the knowledge gap in interventional pulmonology by providing clinicians with unprecedented precision during biopsies.
Target Audience
The primary target audience includes interventional pulmonologists, thoracic surgeons, and other medical professionals involved in the diagnosis and treatment of early-stage lung cancer.
Features
- Miniature optical imaging system integrated into biopsy needles for real-time visualization
- High-resolution microstructure imaging at the distal end of the biopsy needle
- AI-powered image analysis to assist in identifying cancerous tissues
- Enhanced precision in confirming biopsy needle placement within small lung lesions
- Compatibility with existing bronchoscopy equipment and workflows